Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Phenethylamine (PEA) has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Phenethylamine is a direct decarboxylation product of phenylalanine, so the amino acid is the body's own upstream supply. Supplementing phenylalanine raises substrate availability, though the decarboxylase step is not the main fate of dietary phenylalanine and most of it goes to tyrosine or protein. The relationship is real biochemistry, not a demonstrated additive effect.
Tyrosine and phenylalanine cross the blood brain barrier on the same large neutral amino acid carrier, so a large dose of one lowers the entry of the other. Both are also substrates for the same decarboxylase family. Taking both at once does not simply add up, and the direction of the net effect depends on the ratio.
Phenethylamine promotes catecholamine release and caffeine blocks adenosine receptors, so the two arrive at heightened alertness from different directions. Stacked, the cardiovascular effects may add: heart rate and blood pressure responses could be larger than with either alone, though the combination has not been characterised in people. Anyone sensitive to stimulants should count both.
The anhydrous form is simply caffeine without water of crystallisation and behaves the same way once dissolved. Paired with phenethylamine in a preworkout, the stimulant load stacks. The practical issue is total stimulant dose across the whole formula, not the pairing in isolation.
Theanine is added to stimulant blends to soften the sharp edge of the arousal response without cancelling the alertness. With phenethylamine, which has a very short half life and a steep onset, that smoothing is the stated rationale. The evidence for the pairing comes mostly from caffeine studies, not from phenethylamine specifically.
The decarboxylation of phenylalanine to phenethylamine requires pyridoxal 5 phosphate as cofactor, the same cofactor the enzyme uses for dopamine and serotonin synthesis. Adequate B6 status is a prerequisite for the pathway to run at all. This is a cofactor requirement, not evidence that extra B6 increases phenethylamine levels.
Pyridoxal 5 phosphate is the form the decarboxylase actually binds, and pyridoxine has to be phosphorylated and oxidised to reach it. Formulators pick P5P to skip that conversion step. Whether that matters in a person with normal liver function is not established.
Monoamine oxidase B clears phenethylamine within minutes, and it needs an FAD cofactor derived from riboflavin to do it. Riboflavin status therefore sits upstream of how fast phenethylamine is broken down. Note the direction: this supports clearance, not accumulation.
Green tea catechins slow catechol O methyltransferase, which handles the breakdown of the catecholamines phenethylamine helps release. In theory that extends the catecholamine signal. The evidence is mostly enzymatic and the practical size of the effect in a person taking both is unknown.
Because phenethylamine is cleared almost entirely by monoamine oxidase B, anything that slows that enzyme raises and prolongs its exposure. Rhodiola extracts show MAO inhibiting activity in vitro. That is a mechanistic flag worth knowing about rather than a demonstrated interaction in people, and the direction is toward more stimulation, not less.
Combining a monoamine releasing compound with a botanical that acts on monoamine handling is the classic setup for excessive serotonergic or adrenergic signalling. The specific pairing has not been studied. Given the known interaction record of St John's wort with monoamine drugs, the combination is one to raise with a prescriber rather than assemble at home.
5-HTP and phenylalanine feed the same decarboxylase, so heavy loading of one can occupy enzyme capacity that the other needs. Beyond that, stacking two monoamine raising compounds pushes in the same direction on the same clearance enzymes. There is no trial of this pairing and the reasoning is entirely mechanistic.
Sustained sympathetic activation increases urinary magnesium loss, and stimulant blends are typically used by people who train hard and sweat. Magnesium is added to these formulas partly on that logic. It is a plausible offset rather than a documented rescue of any deficit caused by phenethylamine itself.
Nothing specific on file for Phenethylamine (PEA). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Phenethylamine (PEA). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.